Marsh & McLennan Reports Solid Q4 and Full-Year 2025 Results, Announces $2.0B Share Repurchase
Summary
Marsh & McLennan reported solid fourth quarter and full-year 2025 financial results, including 10% GAAP revenue growth and 9% adjusted EPS growth for the full year, alongside $2.0 billion in share repurchases.
Key Events
-
Solid Full-Year 2025 Financial Performance
The company reported full-year 2025 revenue growth of 10% (GAAP) and 4% (underlying), with adjusted operating income increasing 11% and adjusted EPS rising 9% to $9.75.
-
Strong Fourth Quarter 2025 Results
Fourth quarter 2025 revenue increased 9% (GAAP) and 4% (underlying) to $6.6 billion. Adjusted operating income grew 12% and adjusted EPS increased 10% to $2.12.
-
Substantial Share Repurchase Program
Marsh & McLennan repurchased 10.1 million shares for $2.0 billion during 2025, indicating a significant return of capital to shareholders.
-
Strategic Initiatives Underway
The company launched a new brand, successfully completed the integration of McGriff, and announced its three-year 'Thrive' program focused on brand strategy, client value, growth acceleration, and efficiency.
Analysis
Marsh & McLennan Companies reported strong financial results for both the fourth quarter and full year 2025, demonstrating consistent growth across key metrics. The company achieved double-digit GAAP revenue growth and high single-digit adjusted EPS growth for the full year, alongside significant adjusted operating income expansion. The announcement of $2.0 billion in share repurchases in 2025 underscores management's confidence and commitment to returning capital to shareholders. These solid results, coupled with strategic initiatives like the new brand launch and the Thrive program, could be particularly impactful as the stock is currently trading near its 52-week low, potentially signaling an attractive valuation for investors.
At the time of this filing, MRSH was trading at $180.00 on NYSE in the Finance sector, with a market capitalization of approximately $87.3B. The 52-week trading range was $174.18 to $248.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.